Lipella Pharmaceuticals Re-signs Manufacturing Collaboration Agreement with Cook MyoSite to Support LP-310 Clinical Development

• click to rate

  Posted by Two Blokes Jun 4 - Filed in Stock - 9 views
  
  Supports late-stage development and scalable manufacturing for LP-310, a non-steroidal oral rinse therapy for Oral Lichen Planus, a condition with no approved treatments PITTSBURGH, June 4, 2025 – PRISM MediaWire – Lipella Pharmaceuticals Inc.